NEWS

WIRES

OTHER

Lifeline Biotechnologies, Inc. Reminds Shareholders That August 18, 2006 Is the Record Date for the Solos Endoscopy, Inc. Stock Dividend

Lifeline Biotechnologies, Inc. (PINKSHEETS: LBTN) announced today that Friday is the record date for investors to qualify for the Company's Stock Dividend. Lifeline Biotechnologies recently announced that August 18, 2006 will be the date on which the stock dividend will be issued to its shareholders of record as of September 29, 2006.

Lifeline Biotechnologies' shareholders are expected to receive approximately 1 share of SLSE stock for every 100 shares of LBTN stock owned by August 18, 2006. Lifeline Biotechnologies shareholders will maintain their stock ownership of LBTN and will receive a dividend in Solos Endoscopy, Inc., a leading medical instrumentation company with worldwide distribution to major hospitals, surgical centers, and physician's offices. For each shareholder, as of the record date August 18th, 2006, Lifeline will deliver an Information Statement under the Securities Exchange Act of 1934 describing the terms and conditions of the special dividend distribution and the business of Solos Endoscopy.

"With our shareholder dividend announcement, we reaffirm our confidence and optimism in the long term future of the company and continue to execute on our strategy of returning capital to shareholders," stated Jim Holmes, CEO of Lifeline Biotechnologies, Inc.

About Lifeline Biotechnologies, Inc.

Lifeline Biotechnologies develops and acquires undervalued companies which have innovative technology in the Medical, Nutraceutical, and Energy Industries, to increase the growth of the Company. Lifeline Biotechnologies continues to seek out and capitalize on emerging technologies that will change the medical community. More information is available at the company's website: www.lbtn.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.